SG

Swetha Gowder Dyamol

Active Director Director DIN 10177783
DIN 10177783 First appointment May 2023
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2023
Shareholding value •••• Premium profile

About Swetha Gowder Dyamol

Data last updated:

Swetha Gowder Dyamol is a Director at Nife Healthcare Private Limited (since 2023). Nife Healthcare Private Limited reported revenue of ₹1 Lakh (FY 2024).

DIN 10177783
Primary Designation Director
First Appointment 26 May 2023
Oldest Company Age 3 yrs
Largest company Nife Healthcare Private Limited · ₹1 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Nife Healthcare Private Limited U82990KA2023PTC174117
Director26 May 20232023₹1 Lakh (FY 2024)Active

Board colleagues of Swetha Gowder Dyamol

Directorship timeline

Open interactive timeline →
Nife Healthcare Private Limited
Premium access

Shareholding and investment profile for Swetha Gowder Dyamol

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Swetha Gowder Dyamol

Swetha Gowder Dyamol currently holds 1 directorship: Nife Healthcare Private Limited (Director, since 26 May 2023, revenue ₹1 Lakh (FY 2024)).

Swetha Gowder Dyamol was first appointed on 26 May 2023 as Director at Nife Healthcare Private Limited.

The current boards of Swetha Gowder Dyamol's companies include Jayachamarajapura Shadakshariprasad Siddesh (Nife Healthcare Private Limited), Kottal Ambalathara Saniya (Nife Healthcare Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available